| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $937.8M | +34.2% |
| R&D Expense | $666.6M | +2.3% |
| SG&A Expense | $332.5M | +2.0% |
| Operating Income | -$439.5M | +1.8% |
| Pre-tax Income | -$696.1M | -18.5% |
| Income Tax | -$69.5M | -144.1% |
| Net Income | -$626.6M | -12.1% |
| EPS (Basic) | -$8.37 | -7.4% |
| EPS (Diluted) | -$8.37 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $594.0M | +112.3% |
| Short-term Investments | $282.7M | +116.0% |
| Accounts Receivable | $160.8M | +3.3% |
| Inventory | $30.6M | +40.2% |
| Current Assets | $1.22B | +75.6% |
| Total Assets | $1.90B | +11.1% |
| Current Liabilities | $603.1M | +48.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$158.4M | +55.6% |
| Capital Expenditures | $28.4M | -11.2% |
| Investing Cash Flow | -$176.7M | -160.9% |
| Financing Cash Flow | $646.4M | +284.9% |
| Free Cash Flow | -$186.9M | +51.9% |
| -7.4% |
| Long-term Debt |
| $284.2M |
| -50.3% |
| Total Liabilities | $2.71B | +32.2% |
| Stockholders' Equity | -$818.6M | -135.8% |